DBV Technologies SA
0.7560
31-十月-24 10:33:41
15 分钟延时
股票
-0.0070
-0.92%
今日范围
0.7560 - 0.7790
ISIN
FR0010417345
来源
Cboe
-
DBV Technologies to Participate in Upcoming Investor Conference
06 6月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
10 5月 2023 16:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
09 5月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies Reports First Quarter 2023 Financial Results
04 5月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
19 4月 2023 16:09:21 条件 Nasdaq GlobeNewswire
-
DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting
12 4月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Ordinary and Extraordinary General Meeting of April 12, 2023
24 3月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
13 3月 2023 00:30:00 条件 Nasdaq GlobeNewswire
-
07 3月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
02 3月 2023 16:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
02 3月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming AAAAI 2023 Congress
21 2月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
10 2月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
23 1月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
04 1月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
23 12月 2022 00:30:00 条件 Nasdaq GlobeNewswire
-
08 12月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies to Participate in Upcoming Investor Conference
22 11月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies to Highlight New Clinical Data at ACAAI 2022
09 11月 2022 00:30:00 条件 Nasdaq GlobeNewswire
-
DBV Technologies Reports Third Quarter Financial Results and Business Update
03 11月 2022 15:30:00 条件 Nasdaq GlobeNewswire